person · Reporting owner
Smith Michael Alexander
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| INSMED IncINSM · Entity 3174 | Chief Legal Officer | June 22, 2026 | June 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
INSMED Inc
Report date June 22, 2026 · Filed June 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 37,648 |
Reported balance
After 2026-06-22 transaction · row 1
1 source rowRow 1 · 2026-06-22 · Sale · Disposed 1,806 · Balance 37,648 F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 22, 2026 Filed Jun 24, 2026 20:11 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,806 | $95.82 | $173,050.92 |
DisclosureSEC source: 0001870278-26-000020 · wk-form4_1782331897.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,648 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 03, 2026 Filed Jun 5, 2026 20:14 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 2,159 | $102.27 | $220,800.93 |
DisclosureSEC source: 0001870278-26-000017 · wk-form4_1780690451.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,454 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 22, 2026 Filed May 22, 2026 20:25 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 6,149 | $108.47 | $666,982.03 |
DisclosureSEC source: 0001870278-26-000015 · wk-form4_1779481519.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,613 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| May 13, 2026 Filed May 15, 2026 20:07 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,109 | $116.18 | $477,383.62 |
DisclosureSEC source: 0001870278-26-000012 · wk-form4_1778875647.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,762 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 13,989 | $0.00 Strike: $27.89 | $0.00 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · derivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 18,561 Underlying: Common Stock · 13,989 shares Expires 2031-07-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 5,649 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · derivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,633 Underlying: Common Stock · 5,649 shares Expires 2032-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 19,638 | $150.98 | $2,964,945.24 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,871 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 13,989 | $27.89 | $390,153.21 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 30, 2026 Filed Mar 31, 2026 20:13 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 5,649 | $17.07 | $96,428.43 |
DisclosureSEC source: 0001870278-26-000010 · wk-form4_1774988003.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,520 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 20,248 | $0.00 Strike: $17.07 | $0.00 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · derivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,282 Underlying: Common Stock · 20,248 shares Expires 2032-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · derivative.exercise_date: The options become exercisable based on the following vesting schedule: 25% vest on the first anniversary of the grant date and an additional 12.5% vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 15,771 | $156.53 | $2,468,634.63 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,871 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 15,771 shares sold at prices ranging from $156.00 to $156.86 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,151 | $155.06 | $643,654.06 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,642 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 4,151 shares sold at prices ranging from $154.47 to $155.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,852 | $153.93 | $746,868.36 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,793 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 4,852 shares sold at prices ranging from $153.47 to $154.46 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 24, 2026 Filed Feb 25, 2026 21:04 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 20,248 | $17.07 | $345,633.36 |
DisclosureSEC source: 0001870278-26-000008 · wk-form4_1772053483.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 03, 2026 Filed Feb 4, 2026 21:15 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 640 | $156.27 | $100,012.80 |
DisclosureSEC source: 0001870278-26-000006 · wk-form4_1770239741.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,397 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 08, 2026 Filed Jan 8, 2026 22:19 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,053 | $174.17 | $183,401.01 |
DisclosureSEC source: 0001870278-26-000004 · wk-form4_1767910777.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,037 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 07, 2026 Filed Jan 8, 2026 22:19 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 709 | $175.07 | $124,124.63 |
DisclosureSEC source: 0001870278-26-000004 · wk-form4_1767910777.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,090 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 06, 2026 Filed Jan 8, 2026 22:19 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,396 | $173.33 | $241,968.68 |
DisclosureSEC source: 0001870278-26-000004 · wk-form4_1767910777.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,799 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:05 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 27,600 | $0.00 Strike: $177.12 | $0.00 |
DisclosureSEC source: 0001870278-26-000002 · wk-form4_1767733498.xml · derivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,600 Underlying: Common Stock · 27,600 shares Expires 2036-01-02 F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:05 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 5,293 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001870278-26-000002 · wk-form4_1767733498.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,195 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on January 2, 2026 for no consideration. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 27,130 | $0.00 Strike: $23.75 | $0.00 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · derivative · entry 10 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,130 shares Expires 2030-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F10 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,400 | $187.97 | $263,158.00 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 9 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,902 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F9 · price: This is the weighted average sales price representing 1,400 shares sold at prices ranging from $187.88 to $188.13 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,572 | $187.15 | $294,199.80 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 8 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,302 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · price: This is the weighted average sales price representing 1,572 shares sold at prices ranging from $186.61 to $187.53 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 3,636 | $185.93 | $676,041.48 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 7 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 57,874 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 3,636 shares sold at prices ranging from $185.51 to $186.45 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 3,243 | $184.91 | $599,663.13 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 6 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,510 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 3,243 shares sold at prices ranging from $184.50 to $185.48 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,032 | $183.92 | $741,565.44 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,753 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 4,032 shares sold at prices ranging from $183.49 to $184.48 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,286 | $182.60 | $782,623.60 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,785 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 4,286 shares sold at prices ranging from $182.30 to $183.03 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 7,619 | $181.88 | $1,385,743.72 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,071 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 7,619 shares sold at prices ranging from $181.30 to $182.29 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,342 | $181.01 | $242,915.42 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,690 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 1,342 shares sold at prices ranging from $180.29 to $181.19 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| November 03, 2025 Filed Nov 5, 2025 21:08 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 27,130 | $23.75 | $644,337.50 |
DisclosureSEC source: 0001870278-25-000011 · wk-form4_1762376895.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,032 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:26 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionStock Option (right to buy) · Derivative | 12,780 | $0.00 Strike: $30.46 | $0.00 |
DisclosureSEC source: 0001870278-25-000009 · wk-form4_1757021186.xml · derivative · entry 8 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,780 shares Expires 2028-01-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F8 · derivative.exercise_date: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:26 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,183 | $145.89 | $172,587.87 |
DisclosureSEC source: 0001870278-25-000009 · wk-form4_1757021186.xml · nonDerivative · entry 7 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 54,902 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F7 · price: This is the weighted average sales price representing 1,183 shares sold at prices ranging from $145.75 to $146.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:26 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,944 | $145.18 | $717,769.92 |
DisclosureSEC source: 0001870278-25-000009 · wk-form4_1757021186.xml · nonDerivative · entry 6 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 56,085 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F6 · price: This is the weighted average sales price representing 4,944 shares sold at prices ranging from $144.72 to $145.57 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:26 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 8,300 | $144.16 | $1,196,528.00 |
DisclosureSEC source: 0001870278-25-000009 · wk-form4_1757021186.xml · nonDerivative · entry 5 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 61,029 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F5 · price: This is the weighted average sales price representing 8,300 shares sold at prices ranging from $143.72 to $144.71 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:26 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 7,391 | $143.16 | $1,058,095.56 |
DisclosureSEC source: 0001870278-25-000009 · wk-form4_1757021186.xml · nonDerivative · entry 4 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,329 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 7,391 shares sold at prices ranging from $142.70 to $143.63 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:26 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,100 | $142.06 | $156,266.00 |
DisclosureSEC source: 0001870278-25-000009 · wk-form4_1757021186.xml · nonDerivative · entry 3 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,720 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 1,100 shares sold at prices ranging from $141.58 to $142.55 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:26 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,354 | $141.16 | $191,130.64 |
DisclosureSEC source: 0001870278-25-000009 · wk-form4_1757021186.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 77,820 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 1,354 shares sold at prices ranging from $140.58 to $141.50 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 21:26 UTC | INSMED Inc INSM · Entity 3174 | Exercise / conversionCommon Stock | 12,780 | $30.46 | $389,278.80 |
DisclosureSEC source: 0001870278-25-000009 · wk-form4_1757021186.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 79,174 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| July 15, 2025 Filed Jul 15, 2025 21:52 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 933 | $102.51 | $95,641.83 |
DisclosureSEC source: 0001104506-25-000029 · wk-form4_1752616339.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,394 F3 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F4 · price: This is the weighted average sales price representing 933 shares sold at prices ranging from $102.37 to $102.70 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| July 11, 2025 Filed Jul 15, 2025 21:52 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 748 | $96.41 | $72,114.68 |
DisclosureSEC source: 0001104506-25-000029 · wk-form4_1752616339.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,327 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. F2 · balance_after: Includes 357 shares acquired through the Company's 2018 Employee Stock Purchase Plan. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 20:53 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,879 | $73.50 | $138,106.50 |
DisclosureSEC source: 0001628280-25-030045 · wk-form4_1749243207.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,718 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. Read SEC document |
| June 03, 2025 Filed Jun 4, 2025 21:38 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 1,448 | $71.50 | $103,532.00 |
DisclosureSEC source: 0001628280-25-029409 · wk-form4_1749073085.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,597 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:02 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 20,000 | $70.00 | $1,400,000.00 |
DisclosureSEC source: 0001628280-25-029012 · wk-form4_1748980929.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,045 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F3 · price: This is the weighted average sales price representing 20,000 shares sold at prices ranging from $70.00 to $70.04 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 30, 2025 Filed Jun 3, 2025 20:02 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 6,327 | $68.56 | $433,779.12 |
DisclosureSEC source: 0001628280-25-029012 · wk-form4_1748980929.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,045 F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 27, 2025, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. F2 · price: This is the weighted average sales price representing 6,327 shares sold at prices ranging from $68.13 to $68.88 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC | INSMED Inc INSM · Entity 3174 | GrantStock Option (right to buy) · Derivative | 27,100 | $0.00 Strike: $67.22 | $0.00 |
DisclosureSEC source: 0001628280-25-026580 · wk-form4_1747688723.xml · derivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,100 Underlying: Common Stock · 27,100 shares Expires 2035-05-15 F3 · derivative.exercise_date: These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. Read SEC document |
| May 15, 2025 Filed May 19, 2025 21:05 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 5,578 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-026580 · wk-form4_1747688723.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,372 F1 · shares: Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. F2 · price: Each RSU was granted on May 15, 2025 for no consideration. Read SEC document |
| May 14, 2025 Filed May 15, 2025 20:36 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 409 | $65.61 | $26,834.49 |
DisclosureSEC source: 0001628280-25-025995 · wk-form4_1747341358.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,794 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| May 13, 2025 Filed May 15, 2025 20:36 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 4,407 | $67.81 | $298,838.67 |
DisclosureSEC source: 0001628280-25-025995 · wk-form4_1747341358.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,203 F1 · kind: Shares sold to satisfy tax withholding obligations upon the vesting of Restricted Stock Units and to cover related broker fees. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 22:10 UTC | INSMED Inc INSM · Entity 3174 | SaleCommon Stock | 20,650 | $80.90 | $1,670,585.00 |
DisclosureSEC source: 0001628280-25-004458 · wk-form4_1738966239.xml · nonDerivative · entry 2 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,610 F2 · shares: Shares sold to satisfy tax withholding obligations upon the vesting of PSUs and to cover related broker fees. F3 · price: This is the weighted average sales price representing 20,650 shares sold at prices ranging from $80.57 to $81.43 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 22:10 UTC | INSMED Inc INSM · Entity 3174 | GrantCommon Stock | 47,295 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-004458 · wk-form4_1738966239.xml · nonDerivative · entry 1 Smith Michael Alexander · CIK 0001870278 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,260 F1 · shares: Represents shares of common stock acquired upon vesting of Performance Stock Units (PSUs) that were originally granted on January 6, 2022, which vested on February 5, 2025 upon the achievement of the applicable performance and service conditions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.